See our latest announcements, product & service releases, validations and more.

Teiko announces the launch of rapid, low-cost configurable cytometry assays for clinical immune monitoring, offering sponsors over 12K pre-validated configurations run in days at mid-hundreds per sample.

Teiko, a global CLIA-certified immune monitoring lab, today announced that Stingray Therapeutics has selected Teiko to provide mass cytometry-based multi-parameter immuneprofiling services in support of the clinical development of its leading novel innate immunecheckpoint inhibitor Vizenpistat (SR-8541A, ENPP1 inhibitor) targeting therapeutic program.

Teiko's new FFP Phospho Flow Assay Development service provides custom phospho cytometry assay development for PBMCs and TokuKit-preserved whole blood, supporting pharmacodynamic biomarker development, mechanism of action studies, and longitudinal immune monitoring.

A new custom panel cytometry service that quantifies the absolute number of target molecules per cell, so drug developers can compare antigen levels across markers. See how the antigen levels compare between patient groups, disease, and immune cell populations.

111 human mass cytometry markers, 24 human spectral flow cytometry markers, and 44 NHP markers validated on fixed whole blood samples

Li-Chun Cheng, PhD, shares new findings showing TokuKit-processed whole blood samples maintain immune cell frequencies and expression levels (R > 0.99 compared to fresh sample) for 2-years, making the need for live sample processing a thing of the past.

Teiko's TokuProfile Dashboard now includes antigen density visualizations. For projects that include per-cell antigen density measurement, view the absolute number of target molecules per cell across every profiled immune population, alongside your existing frequency and marker expression results.

Teiko has released a new dashboard feature that adds inter-run CV bands to Immune Changes plots, overlaying assay variability derived from control samples to help determine whether observed differences reflect real biology or could be explained by technical variation in the assay.

Teiko expanded its Artificial Immunologist AI assistant across all analysis pages in its clinical trial platform. New capabilities include natural language plot configuration, a persistent chat interface, and one-click suggested next steps. No immunology degree required.

Our new CDISC export feature automates all 24 Cell Phenotyping (CP) domain columns instantly. This saves critical time, ensures data reliability, and accelerates your path to regulatory drug approval by eliminating tedious, high-risk data wrangling.

Teiko announces the launch of Custom Spectral Flow Cytometry Panels, a new service designed for teams that need panels tailored to their drug targets, biology, and clinical trial goals.

To account for cases where samples might be left on the bench at a clinical trial site and fixed for longer than 15 minutes, we ran a study evaluating the impact of extended fixation—15 minutes, 30 minutes, 1 hour, and 2 hours—on both population frequency and functional subset readouts.

In an R&D study, TokuKit-fixed samples maintained immune population and functional subset frequencies up to two freeze–thaw cycles using a 43-marker CyTOF panel

Samples processed with different lots of TokuKit see a mean coefficient of variation of <6% across cell population and functional subset frequencies.

Teiko announced new validation data demonstrating that blood samples collected with TokuKit and stored at –80°C maintain stable immune cell frequencies and preserve both surface and intracellular protein expression for at least two years. These results confirm that the immune cell biology captured at the time of collection remains intact and reproducible, whether samples are processed within days or years later.

New filtering feature on Top 100 Stats lets you immediately focus on the populations, markers, and endpoints most relevant to your program

A new interactive planner helps drug developers determine the right blood volume, or the reliability achievable with a fixed volume, to ensure robust immune readouts and protect key PD endpoints.

‘Top Statistical Results’ was built to solve a major challenge in immune profiling for clinical trials: large cytometry datasets contain thousands of possible comparisons, and important signals can go unnoticed unless you know exactly where to look. Top Statistical Results automatically tests all comparisons across populations, markers, analysis types, and endpoints, then surfaces the top 100 most statistically significant results. 

We shared three posters addressing challenges from sample collection to analysis and released new performance data for TokuTBNK, our standardized whole blood TBNK cytometry service for global PK and PD assessment.

Teiko announces the launch of TokuTBNK, a high-precision cytometry service designed to deliver reproducible pharmacokinetic and pharmacodynamic (PK/PD) readouts in clinical trials.

Zumutor Biologics has selected Teiko to rapidly develop and validate a custom 42-marker mass cytometry panel to support its novel biologics pipeline. The collaboration includes high-throughput PBMC profiling and data analysis through Teiko’s TokuProfile™ Dashboard, enabling deep immune insights into the mechanism of action and pharmacodynamics of Zumutor’s NK checkpoint therapeutic candidate, ZM008.

A new Dashboard feature automatically ranks the most statistically significant immune findings across all populations, markers, analysis types, and endpoints, helping you move from raw data to insights faster.

Your dashboard now offers real-time blood specimen tracking for clinical trials, easing worries about sample status. Monitor PBMCs and whole blood from collection to analysis, including storage, processing dates, and results readiness. Central lab programs using TokuKit gain kit inventory, expirations, and IDs for streamlined logistics. Included for all clients, no setup required.

High-dimensional cytometry dataset from 35 NSCLC PBMC samples from the National Cancer Institute now available on Teiko Dashboard

Using a 25-marker spectral flow cytometry panel, we found that a CytoChex-to-TokuKit workflow preserves immune cell populations and functional markers, demonstrating compatibility without compromising results. 

We’ve uploaded new high-dimensional cytometry data from 70 melanoma PBMC samples to help you explore biomarkers of safety and efficacy.

From 0.5 to 3 mL, TokuKit preserves immune profiles with ±2% variation, giving clinical teams confidence in their data regardless of blood volume.

Our upgraded Sample Overview dashboard is now standard for all partners. It replaces a simple pass/fail with a robust, multi-factor score that checks post-thaw cell count post-thaw viability percentage, live singlets acquired, and non-granulocytes acquired. This allows developers to instantly assess sample quality and read direct scientist comments, enabling faster, more confident decisions

Teiko releases "Download All" to bulk retrieve gating gating plots for clinical trial samples

Teiko Bio now offers real-time kit and sample tracking in the Teiko Dashboard to monitor samples from collection to results with clear status updates, eliminating the need for emails or calls

Instantly verify flow cytometry data with Teiko's new "Hover Over Gating" feature! See underlying gating plots and metadata by simply hovering over boxplot data points. Accelerate drug development by gaining immediate visual confidence in data accuracy. Learn more at app.teiko.bio.

Teiko's "Pocket Immunologist" now offers advanced functional marker analysis. This upgrade simplifies interpreting complex functional marker expression data in specific cell types, providing instant insights on cell and marker relevance in the context of disease and treatment.

Heatmaps provides new way to view cytometry data in Teiko Dashboard.

Teiko releases AI-powered Pocket Immunologist to help translational and biomarker teams to accelerate insights into cytometry data.

With TokuCompute, Teiko offers expert cytometry analysis as a service to help biomarker and translational teams overcome bottlenecks in analyzing complex clinical trial data. Teiko is a shared a Cell Engine project; analyzes the data and provides results through an interactive cytometry dashboard in days. Two analysis tiers are offered: Core Compute for immune composition and statistical comparisons, and Premier Compute, which adds unsupervised clustering and visualizations.

Teiko dashboard release: Log₂ Fold change now available as a baseline normalization method

A new publication by Revach et al. in Cell Reports Medicine from Massachusetts General Hospital (MGH) uncovers a key mechanism of immune checkpoint blockade (ICB) resistance in melanoma: the emergence of CD38⁺ exhausted CD8⁺ T cells post-treatment that correlates with ICB resistance.

Samples Overview is now live on the Teiko Dashboard , bringing sample metadata, QC status, and gating plots into one integrated view.

Teiko’s new TokuPilot service makes immune cytometry easy with a structured, ready-to-run pilot for PBMC and whole blood samples.

Teiko’s new Samples QC feature brings everything into one centralized dashboard ,so you can quickly review QC metrics and ensure every cytometry specimen is up to standard.

We've integrated advanced batch normalization into our core pipeline, simplifying cytometry for global clinical trials. This solution eliminates the need for users to fine-tune parameters, ensuring accurate results.

TokuKit-fixed blood samples can be stored for at least 14 days in a fridge. This is designed to support global clinical trial sites that don't have access to -80C freezers.

We’re thrilled to announce two features to the TokuProfile Dashboard for multiparameter cytometry datasets: “p-values on demand” and the ability to assess the frequency of any cell population as a percent of any preceding ancestor.

Can’t stand hunting through a cytometry dashboard to find the exact filters to be able to do statistically valid comparisons? Neither can we.

Teiko presents research at AACR IO, showing a 48% cell count drop in blood processed after 72 hours.

Teiko’s TokuFocus offers a 10-marker TBNK panel for $1,000 per specimen, with an option to upgrade to a full 25/41-marker panel for $900 within a year.

Teiko’s new cytometry add-on provides absolute cell counts alongside relative frequencies. We integrate external CRO data with Teiko’s analysis, offering precise immune cell quantification for better treatment impact assessment.

Teiko launches TokuKit for spectral flow cytometry, analyzing 146 immune populations in fixed whole blood. Offers high precision, month+ stability.

This update adds a drop-down menu for selecting top-level populations like T cells or monocytes. Users can now visualize cell subsets as fractions of any chosen population, improving detailed immune analysis.

Teiko enhances data export with baseline normalization, collapsible filters for easier navigation, seamless sample appending, and improved statistical analysis for missing samples in clinical trials.

Teiko partners with Obsidian Therapeutics to provide CLIA-validated, 25-marker spectral flow cytometry for OBX-115 trial, profiling hundreds of immune cell subsets in patients’ blood.

Teiko is excited to announce that two posters have been accepted for presentation at the 2024 Society for Immunotherapy of Cancer (SITC) annual meeting in Houston from November 8 - 10th.

Teiko accepts two posters at the International Clinical Cytometry Conferences (ICCS) in Seattle. On Monday, October 7, two poster presentations will take place regarding assessing normalization methods for CyTOF data and analyzing fixed whole blood samples by high-dimensional spectral cytometry.

Introducing our new feature, Dynamic Baseline, now available on app.teiko.bio. This feature allows users to set any time point, such as the start of lymphodepletion (e.g., C1D15), as the new baseline for normalization, providing more flexibility when analyzing longitudinal data across key clinical milestones.

Simple way to order sample collection TokuKits for clinical trials.